MS Speaks

HERE FOR 19 YEARS--for people with an interest in multiple sclerosis

Pages: [1]

		Subject / Started by	Replies / Views	Last post
		(Abst.) Cladribine transfer into human milk: A case study (Abst.) Cladribine transfer into human milk: A case study agate · June 27, 2020, 08:54:06 pm From Multiple Sclerosis Journal, June 8, 2020--"Cladribine transfer into human milk: A case study":https://journals.sagepub.com/... 0 Replies · 266 Views Started by agate	0 Replies 266 Views	June 27, 2020, 08:54:06 pm by agate
		Cladribine (Mavenclad) approved for active SPMS, RRMS Cladribine (Mavenclad) approved for active SPMS, RRMS agate · April 01, 2019, 04:00:21 pm Another MS drug has been approved. Like siponimod (Mayzent), it turns out to be for SPMS only if it's still active SPMS (still h... 0 Replies · 320 Views Started by agate	0 Replies 320 Views	April 01, 2019, 04:00:21 pm by agate
		(Lancet) Cladribine and other new MS treatments--at what long-term risk? (Lancet) Cladribine and other new MS treatments--at what long-term risk? agate · February 22, 2014, 08:47:16 am The Lancet Neurology, vol. 13, March 2014, pp. 235-37, contains a short article in its "Comments" section, "New treatments for m... 0 Replies · 340 Views Started by agate	0 Replies 340 Views	February 22, 2014, 08:47:16 am by agate

Pages: [1]

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

Create your own free forum at CreateAForum.com | Report Abuse